Quercetin decreases oxidative stress, NF-κB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats

Journal of Nutrition

Volumn 135, Issue 10, 2005, Pages 2299-2304

  Dias, Alexandre Simões ^a   Porawski, Marilene ^b   Alonso, María ^c   Marroni, Norma ^a,b   Collado, Pilar S ^c   González Gallego, Javier ^c  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

^c UNIVERSITY OF LEÓN   (Spain)

Author keywords

Diabetes; Nitric oxide; Nuclear factor B; Oxidative stress; Quercetin

Indexed keywords

BIOLOGICAL MARKER; CATALASE; GLUCOSE; GLUTATHIONE PEROXIDASE; HYDROPEROXIDE; I KAPPA B ALPHA; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; QUERCETIN; STREPTOZOCIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; ENZYME ACTIVITY; ENZYME DEGRADATION; GEL MOBILITY SHIFT ASSAY; GLUCOSE BLOOD LEVEL; LIVER; MALE; MEDIATOR RELEASE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; TISSUE INJURY; WESTERN BLOTTING;

ANIMALIA; RATTUS NORVEGICUS;

EID: 26444581298     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/135.10.2299     Document Type: Article

References (64)

1. Ceriello A. Oxidative stress and glycemic regulation. Metabolism. 2000;49:27-9.
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414:813-20.
3. Baynes W. Chemical modification of protein by lipids in diabetes. Clin Chem Lab Med. 2003;41:1159-65.
4. Wolff SP, Dean RT. Glucose autoxidation and protein modification. The potential role of 'autoxidative glycosylation' in diabetes. Biochem J. 1987;245:243-50.
5. Wolff SP, Jiang ZY, Hunt JV. Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radic Biol Med. 1991;10:339-52.
6. Wojtczak L, Schonfeld P. Effect of fatty acids on energy coupling processes in mitochondria. Biochim Biophys Acta. 1993;1183:41-57.
7. King GL, Loeken MR. Hyperglycemia-induced oxidative stress in diabetic complications. Histochem Cell Biol. 2004;122:333-8.
8. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress-activated signaling pathways: a unifying hypothesis type 2 diabetes. Endocr Rev. 2002;23:599-622.
9. Spitaler MM, Graier WF. Vascular targets off redox signaling in diabetes mellitus. Diabetologia. 2002;45:476-94.
10. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury. I. Basic mechanisms and in vivo monitoring of ROS. Circulation. 2003;108:1912-6.
11. Stadler K, Jenei V, von Bolcshazy G, Somogyi A, Jakus J. Role of free radicals and reactive nitrogen species in the late complications of diabetes mellitus in rats. Orv Hetil. 2004;145:1135-40.
12. Marchioli R, Scweiger C, Levantesi G, Gavazzi L, Valagussa F. Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data. Lipids. 2001;36:S53-65.
13. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE) randomized placebo-controlled trial. Lancet. 2000;356:1213-8.
14. Gaede P, Poulsen HE, Parving HH, Pedersen O. Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in type 2 diabetic patients. Diabet Med. 2001;18:756-60.
15. Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zimman B, Bosch J, Dagenais G, Mann J, Gerstein H. C. Effects of vitamin E on cardiovascular and microvascular outcomes in high risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care. 2002;25:1919-27.
16. Hertog MGL, Hollman PCH. Potential health effects of the dietary flavonol quercetin. Eur J Clin Nutr. 1996;50:63-71.
17. Pawlikowska-Pawlega B, Guszecki WI, Misiak LE, Gawron A. The study of the quercetin action on human erythrocyte membranes. Biochem Pharmacol. 2003;66:605-12.
18. Huk I, Brovkovich V, Nanobash V, Weigel G, Neumayer C, Partyka L. Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study. Br J Surg. 1998;85:1080-5.
19. Erden Inal M, Kahraman A. The protective effect of flavonol quercetin against ultraviolet A induced oxidative stress in rats. Toxicology. 2000;54:21-9.
20. Duarte J, Galisteo M, Ocete MA, Pérez-Vizcaino F, Zarzuelo A, Tamargo J. Effect of chronic quercetin treatment on hepatic oxidative status in spontaneously hypertensive rats. Mol Cell Biochem. 2001;221:155-60.
21. Peres W, Tuñón MJ, Mato S, Collado PS, Marroni N, González-Gallego J. Hepatoprotective effects of the flavonoid quercetin in rats with biliary obstruction. J Hepatol. 2000;33:742-50.
22. Wadsworth TL, Koop DR. Effects of Gingko biloba extract (Egb 761) and quercetin on lipopolysaccharide-induced release of nitric oxide. Chem Biol Interact. 2001;137:43-58.
23. Igura K, Ohta T, Kuroda Y, Kaji K. Resvetatrol and quercetin inhibit angiogenesis in vitro. Cancer Lett. 2001;171:11-6.
24. Yang K, Lamprecht SA, Liu Y, Shinozaki H, Fan K, Leung D. Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane-treated mouse colon. Carcinogenesis 2000;21:1655-60.
25. Moreira A, Fraga C, Alonso M, Collado PS, Zettler C, Marroni N, Gonzalez-Gallego J. Quercetin prevents oxidative stress and NF-κB activation in gastric mucosa of portal hypertensive rats. Biochem Pharmacol. 2004;68:1939-46.
26. Muraoka K, Shimizu K, Sun X, Tani T, Izumumi R, Miwa K, Yamamoto K. Flavonoids exert diverse inhibitory effects on the activation of NF-κB. Transplant Proc. 2002;34:1335-40.
27. Mahesh T, Menom VP. Quercetin alleviates oxidative stress in streptozotocin-induced diabetic rats. Phytother Res. 2004;18:123-7.
28. Coskum O, Kanter M, Korkmaz A, Oter S. Quercetin, a flavonoid antioxidant, prevents and protects streptozotocin-induced oxidative stress and β-cell damage in rat pancreas. Pharmacol Res. 2005;51:117-23.
29. Stadler K, Jenei V, Bolcshazy G, Somogyi A, Jakus J. Increased nitric oxide levels as an early sign of premature aging in diabetes. Free Radic Biol Med. 2003;35:1240-51.
30. Seven A, Guzel S, Seymen O, Civelek S, Bolayirh M, Uncu M, Burcak G. Effect of vitamin E supplementation on oxidative stress in streptozotocin induced diabetic rats: investigation of liver and plasma. Yonsei Med J. 2004;45:703-10.
31. National Academy of Sciences. The Guiding Principles for Research Involving Animals, Bethesda: National Institutes of Health; 1991.
32. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95;351-8.
33. González-Flecha B, Llesuy S, Boveris A. Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of liver, heart, and muscle. Free Radic Biol Med. 1991;10:41-7.
34. Chance B, Machley AL. Assays of catalases and peroxidases. Methods Enzymol. 1995;2:764-75.
35. Flohe L, Guntzler WA. Glutathione peroxidase. Methods Enzymol. 1974;105:115-21.
36. Misra HP, Fridovich I. (1972) The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972;247:3170-5.
37. Essani NA, McGuire GM, Manning AM, Jaeschke H. Endotoxin-induced activation of the nuclear transcription factor NF-κB in hepatocytes, Kupffer cells and endothelial cells in vivo. J Immunol. 1996;156:2956-63.
38. Obrosova I, Cao X, Greene DA, Stevens MJ. Diabetes-induced changes in lens antioxidant status, glucose utilization and energy metabolism: effect of DL-α-lipoic acid. Diabetologia. 1998;41:1442-50.
39. Maritim AC, Sanders RA, Watkins III JB. Effects of α-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetics rats. J Nutr Biochem. 2003;14:288-94.
40. Yilmaz HR, Uz E, Yucel N, Altuntas I, Ozcelik N. Protective effect of caffeic acid phenethyl ester (CAPE) on lipid peroxidation and antioxidant enzymes in diabetic rat liver. J Biochem Mol Toxicol. 2004;18:234-8.
41. Cho SY, Park JY, Park EM, Choi MS, Lee MK, Jeon SM, Jang MK, Kim MJ, Park YB. Alteration of hepatic antioxidant enzyme activities and lipid profile in streptozotocin-induced diabetic rats by supplementation of dandelion water extract. Clin Chim Acta. 2002;317:109-17.
42. Ozkaya YG, Agar A, Yargicoglu P, Hacioglu G, Bilmen-Saikcioglu S, Ozen I, Aliciguzel Y. The effect of exercise on brain antioxidant status of diabetic rats. Diabetes Metab. 2002;28:377-84.
43. Wahaieb SA, Godin DV. Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rat. Effects of insulin treatment. Diabetes. 1987;36:1014-8.
44. Sekeroglu MR, Sahin H, Dulger H, Algun E. The effect of dietary treatment on erythrocyte lipid peroxidation, superoxide dismutase and glutathione peroxidase, and serum lipid peroxidation in patients with type 2 diabetes mellitus. Clin Biochem. 2000;33:669-74.
45. Aliciguzel Y, Ozen I, Asian M, Karayalcin U. Activities of xanthine oxidoreductase and antioxidant enzymes in different tissues of diabetic rats. J Lab Clin Med. 2003;142:172-7.
46. Huang WC, Juang SW, Liu IM, Chi TC, Cheng JT. Changes of superoxide dismutase gene expression and activity in the brain of streptozotocin induced diabetic rats. Neurosci Lett. 1999;275:25-8.
47. Sanders RA, Rauscher FM, Watkins JB. Effects of quercetin on antioxidant defense in streptozotocin-induced diabetic rats. J Biochem Mol Toxicol. 2001;15:143-9.
48. Horie S, Ishii H, Suga T. Changes in peroxisomal fatty acid oxidation in the diabetic rat liver. J Biochem. 1981;90:1691-6.
49. Matkovics B. Effect of plant and animal lesions on superoxide dismutase activities. In: McCord G, Michelson AM, Fridovich I, editors. Superoxide and superoxide dismutase, New York: Academic Press; 1977. p. 501-15.
50. Nishikawa T, Edelstein D, Du XL, Yamagishi SI, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000;404:787-90.
51. Hofmann MA, Schiekofer S, Isermann B, Kanitz M, Henkels M, Joswig M, Treusch A, Morcos M, Weiss T, et al. Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative stress-sensitive transcription factor NF-κB. Diabetologia. 1999;42:222-32.
52. Ho E, Chen G, Bray TM. A-Phenyl-tert-butylnitroen (PBN) inhibits NF-κB activation offering protection against chemically induced diabetes. Free Radic Biol Med. 2000;28:604-14.
53. Kowluru RA, Koppolu P, Chakrabarti S, Chen S. Diabetes-induced activation of nuclear transcriptional factor in the retin, and its inhibition by antioxidants. Free Radic Res. 2003;37:1169-80.
54. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell. 1997;91:243-52.
55. Staal FJT, Roederer M, Herzenberg LA, Herzeneberg LA. Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A. 1990;87:9943-7.
56. Romics L, Kodys K, Dolganiuc A, Graham L, Velayudham A, Mandrekar P, Szabo G. Diverse regulation of NF-κB and peroxisome proliferators- activated receptors in murine non-alcoholic fatty liver. Hepatology. 2004;40:376-85.
57. Xie Q, Nathan C. The high-output nitric oxide pathway: role and regulation. J Leukoc Biol. 1994;56:576-82.
58. Peet GW, Li J. IKappaB kinases alpha and beta show a random sequential kinetic mechanism and are inhibited by staurosporin and quercetin. J Biol Chem. 1999;274:32655-61.
59. Prabhakar SS. Role of nitric oxide in diabetic nephropathy. Semin Nephrol. 2004;24:333-44.
60. Madar Z, Kalet-Litman S, Stark AH. Inducible nitric oxide synthase activity and expression in liver and hepatocytes of diabetic rats. Pharmacology. 2004;73:106-12.
61. Llorens S, Nava E. Cardiovascular diseases and the nitric oxide pathway. Curr Vasc Pharmacol. 2003;1:335-46.
62. Cho, S. Y., Park, S. J., Kwon, M. J., Jeong, T. S., Bok, S. H., Choi, W. Y., Jeong, W. I., Ryu, S. Y., Do, S. H., Lee, C. S., Song, J. C. & Jeong KS. Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-kappaB pathway in lipopolysaccharide-stimulated macrophage. Mol Cell Biochem. 2003;243:153-60.
63. Mu MM, Chakravortty D, Sugiyama T, Koide N, Takahashi K, Mori I, Yoshida T, Yokochi T. The inhibitory action of quercetin on lipopolysaccharide-induced nitric oxide production in RAW 264. 7 macrophage cells. J Endotoxin Res. 2001;7:431-8.
64. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr. 2005;81:2435-55.